Earnings
0
Econ Events
—
Movers
20
Fear & Greed
69

Wall Street Slips as Oil Surges, Crypto Slides, and Treasury Yields Hit 2007 Highs

2026-09-15 · By SEPT AI

← 2026-09-1475 summariesAll days2026-09-16 →

U.S. equities closed lower on Tuesday, September 15, 2026, as a potent mix of rising crude prices, a spike in long-term Treasury yields to levels not seen in nearly two decades, and a sharp selloff in cryptocurrency markets weighed on investor sentiment. The major indices gave back early gains, with the tech-heavy Nasdaq bearing the brunt of the selling pressure.

The S&P 500, tracked by the SPY ETF, slipped 0.35% to close at $757.42, while the Dow Jones Industrial Average (DIA) fell 0.36% to $521.32. The Russell 2000 (IWM) dropped 0.51% to $285.16, and the Nasdaq-100 (QQQ) underperformed, losing 0.60% to end at $704.55. Despite the day’s losses, the Fear & Greed Index remained firmly in "Greed" territory at 69, suggesting underlying bullish sentiment has yet to fully crack.

Energy Crisis Deepens, Crude Hits $106

The dominant macro narrative on Tuesday was the escalating energy crisis. Crude oil surged to $106 per barrel, its highest level in five months, according to data from the OIH ETF. The rally was fueled by reports that Saudi Aramco had deferred and cancelled some September crude cargoes meant for European refiners following the closure of its East-West pipeline to the Red Sea. Ongoing Saudi military strikes against Yemen’s Houthi rebels and a tight global diesel market—which hit a record high—added further upward pressure on prices.

The geopolitical dimension was amplified by a Washington Post report that the Trump Administration is preparing a multibillion-dollar sale of 2,000-pound bombs to Israel, the largest single sale of the controversial munition in recent years. This development underscored the heightened state of global tensions, which typically supports energy and defense stocks while pressuring broader risk appetite.

The 10-year Treasury yield climbed to its highest level since 2007, a stark reminder of the tightening financial conditions that have been a persistent headwind for equities. With a Federal Reserve decision looming, the yield move added a layer of uncertainty, particularly for growth and technology stocks that are sensitive to higher discount rates.

₿Crypto Meltdown on CLARITY Act Failure

The cryptocurrency market suffered a significant blow as the CLARITY Act failed to pass a Senate vote. Bitcoin fell to $76,000, while Ethereum, XRP, and Dogecoin all dumped sharply. The failure of the legislation, which had been seen as a potential catalyst for regulatory clarity and institutional adoption, sent shockwaves through the digital asset space.

Coinbase (COIN) slid 6% as the odds of the bill’s passage crashed to just 15% ahead of the vote. XRP was particularly hard hit, with analysts warning that the token could crater if the CLARITY Act failed. The broader crypto selloff also dragged down related equities and tokens, with XRPT and XXRP both falling nearly 20% to $29.34 and $27.43, respectively. Bitcoin-related trust BTCT lost 19.61% to close at $1.23.

📊Sector and Stock Movers: A Day of Extremes

The day’s biggest mover was RETO, which exploded 874.29% to $3.41 on massive volume of nearly 189 million shares, though no specific catalyst was immediately identified. MEDS surged 82.14% to $1.63 after being halted on a circuit breaker to the upside, with traders pointing to a short squeeze as the primary driver.

On the downside, FEED cratered 69.46% to $1.02, while PLCE fell 22.87% to $1.91. Several stocks tied to the crypto and blockchain space were among the worst performers, reflecting the sector-wide rout.

In the healthcare space, BioMarin Pharmaceutical (BMRN) slid after announcing it would discontinue development of VOXZOGO for children with Noonan syndrome, a significant pipeline setback. GT Biopharma (GTBP) also traded lower despite announcing FDA clearance for its IND application for GTB-5550 in multiple myeloma, a move that typically would be viewed positively.

Tempest Therapeutics (TPST) was a notable gainer, rising after the company entered into an exclusive option agreement to license Hebei Senlang Biotechnology’s CD7-targeted lentiviral vector platform and a portfolio of in vivo CAR-T product candidates. Wah Fu Education (WAFU) also rallied after its AI agent project won a government innovation review, qualifying for up to $1.1 million in subsidies.

💰Earnings and Corporate News

NanoXplore (TSX:GRA) provided a disappointing outlook, forecasting FY2028 sales of $160 million to $170 million, well below the $210.25 million analyst estimate. Corvex (MOVE) reported a wider-than-expected Q2 loss of $5.12 per share, though revenue surged to $3.8 million from just $103,000 a year ago.

In M&A, Flag Ship Acquisition (FSHP) announced a merger agreement with Bluechip & Co. Holdings, issuing 40 million purchaser ordinary shares and reflecting a company net value of $400 million. Ashland (ASH) spiked higher on an unconfirmed analyst report suggesting the company is running a sales process, with Apollo Global Management and Carlyle Group among the private equity firms showing interest.

Rocket Lab (RKLB) secured funding for an Iridium buyout, sending shares higher. Meanwhile, Pulse Biosciences (PLSE) fell after filing a prospectus supplement for an at-the-market common stock offering of up to $85 million.

🏦Smart Money: Insider Buying Spree

Insider buying activity was notably robust on Tuesday, with several companies seeing significant purchases from executives and directors. Ecolab (ECL) led the pack with four insider buys totaling $2.7 million. Erie Indemnity (ERIE) saw three buys worth $1.4 million, while MercadoLibre (MELI) had three buys totaling $1.2 million. Campbell’s (CPB), Loews (L), and Conagra (CAG) also saw insider purchases in the millions. Huntington Bancshares (HBAN) had seven insider buys worth $617,560, signaling confidence in the regional banking sector despite the challenging macro environment.

🔮Looking Ahead

Investors will be closely watching the Federal Reserve’s next policy decision, with the 10-year yield at its highest since 2007 adding pressure on the central bank to provide clarity on its rate path. The energy crisis will remain front and center, particularly as diesel prices hit record highs and geopolitical tensions in the Middle East show no signs of abating.

On the corporate calendar, the fallout from the CLARITY Act failure will continue to ripple through crypto-related equities, while earnings reports from companies like NanoXplore and Corvex will be scrutinized for broader economic signals. The market’s ability to absorb higher yields and geopolitical shocks will be tested in the sessions ahead.

Explore More

📊
Stock Splits
Upcoming and recent splits
🎯
Low Float Stocks
High volatility candidates
📚
Learn Trading
368 articles and guides

Automate your trading strategy

Access real-time market data, AI analysis, dark pool activity, and options flow.

Start Free Trial